SARS-CoV-2-IN-33 is a small molecule inhibitor with dual research applications. It demonstrates binding affinity for the SARS-CoV-2 main protease (Mpro, PDB: 6LU7) and exhibits anti-proliferative activity in cancer cell studies, making it a compound for investigating both COVID-19 and oncology.
Molekulargewicht:
526.58
CAS Nummer:
[299919-79-2]
Formel:
C30H30N4O5
Target-Kategorie:
Others,SARS-CoV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten